NG Knowles, MA Landchild, WY Fujimoto, SE Kahn - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Fasting plasma glucose (5.3 ± 0.1 vs. 5.1 ± 0.1 mmol/l; means ± SEM), immunoreactive
insulin (IRI) (68 ± 7 vs. 57 ± 6 pmol/l) and amylin-like immunoreactivity (ALI) (5.5 ± 0.6 vs. 4.7
± 0.7 pmol/l) were similar in relatives and control subjects, respectively. Relatives were ... Cited by 24 - Related articles - BL Direct - All 6 versions
SE Kahn, CB Verchere, S Andrikopoulos, PJ … - DIABETES-NEW …, 1998 - Am Diabetes Assoc Islet amyloid is a characteristic feature of type 2 dia- betes. Its major component is the normal
-cell secretory product amylin, or islet amyloid polypeptide (IAPP). To determine whether increased
or disproportionate release of amylin may explain the propensity for amy- loid deposition ... Cited by 42 - Related articles - BL Direct - All 4 versions
S Enoki, T Mitsukawa, J Takemura, M … - Diabetes Res Clin …, 1992 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Plasma islet amyloid polypeptide
levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes
mellitus. Author: Enoki, S : Mitsukawa, T : Takemura, J : Nakazato ... Cited by 39 - Related articles - Cached - All 3 versions
- ►endojournals.org S Makimattila, MS Fineman, H Yki-Jarvinen - Journal of Clinical …, 2000 - Endocrine Soc This study was undertaken to characterize first and second phase secretory profiles of total and
nonglycosylated amylin and insulin and to determine whether excessive glycosylation of amylin
or hyperamylinemia is a feature of abnormal glucose tolerance in humans. Plasma ... Cited by 10 - Related articles - BL Direct - All 4 versions
A Kautzky-Willer, K Thomaseth, B Ludvik, P Nowotny, D … - Diabetes, 1997 - Am Diabetes Assoc Recent research indicates that islet amyloid pancreatic polypeptide (IAPP) might have a regulatory
effect on beta-cell insulin processing and secretion. To study such interaction in more detail,
IAPP secretion and kinetics and the serum concentrations of proinsulin were assessed ... Cited by 33 - Related articles - BL Direct - All 4 versions
- ►physiology.org … , CB Verchere, S Andrikopoulos, SE Kahn - American Journal of …, 1998 - Am Physiological Soc Aging is associated with an increased risk of type 2 diabetes. To determine whether the insulin
resistance of aging is associated with an increase in amylin release or whether amylin release
parallels the reduction in insulin release, we studied 10 older (72 ± 2 yr) and 9 young (25 ... Cited by 27 - Related articles - BL Direct - All 5 versions
SE Kahn, WY Fujimoto, DA D'Alessio, JW Ensinck … - Horm Metab …, 1991 - thieme-connect.com Islet amyloid polypeptide (IAPP) has been shown to be actively secreted by the pancreatic
B-cell along with insulin. To determine whether the modulation of B-cell IAPP secretion is similar
to that of insulin, we assessed IAPP release in response to glucose at 4 different ... Cited by 16 - Related articles - All 4 versions
[CITATION] Increased ß-cell secretory demand is not the simple explanation for inefficient …
A Kautzky-Willer, K Thomaseth, G Pacini, M Clodi, B … - Diabetologia, 1994 - Springer Summary Although it is generally accepted that islet amyloid polypeptide is cosecreted with
insulin, rela- tively few data on its kinetics are available. We there- fore studied the dynamics
of islet amyloid polypeptide release following oral and frequently sampled in- travenous ... Cited by 49 - Related articles - BL Direct - All 3 versions
